Together the Companies will Jointly Promote the Rapid Development of Digital Surgery in China
Beijing, China, October 25, 2019 – Johnson & Johnson Medical (Shanghai) Ltd. today announced that it has entered a co-marketing and distribution agreement, as well as an R&D agreement, with TINAVI, the market leader in orthopaedic robotics in China. This strategic collaboration will allow DePuy Synthes1, the orthopaedics business of Johnson & Johnson Medical Devices Companies*, to bring TINAVI’s robotic solutions for spine and trauma surgery to the highly competitive China orthopaedics implant market. To date, the system is the only arm-based robotic technology with multiple indications approved for use in spine and trauma in China.
The TINAVI robotic platform, approved by the National Medical Products Administration (formerly the China Food and Drug Administration) in 2016, consists of a robot arm, intraoperative planning interface and integrated navigation. The sophisticated robotic arm is designed for maximum clinical reach, can be run in motorized or manual mode, is surgeon driven and has a small footprint. The integrated navigation features include intra-operative 3D imaging, optical navigation and intra-operative screw planning.
“The signing of this agreement is an important milestone in the field of digital surgery both in China and for the DePuy Synthes business globally.” said Will Song, President of Johnson & Johnson Medical Devices China Ltd. “We will work to create an open innovation ecosystem, promote digital and technological medical innovation, provide insights for the Chinese medical industry through local collaboration, optimize patient experience, and help upgrade the health industry, so that more people can access more convenient and better medical services to achieve the great vision of 'Healthy China 2030'.”
The agreement with TINAVI aligns with our aim to build a connected digital environment where technologies that enhance surgical performance, education and monitoring as well as help guide patients through to full recovery are connected – pre, intra and post-operatively across the continuum of care.
About the Johnson & Johnson Medical Companies Shanghai
Founded in 1994, Johnson & Johnson Medical (Shanghai) Ltd, affiliated Johnson & Johnson Medical (China) Ltd., mainly engaged in production and sales of advanced medical devices, with businesses ranging from cardiac and cerebrovascular diseases treatment, suture, minimally invasive surgery, orthopedics, women health, sterilization, etc. in China. With a workforce of over 3,500 employees, the company has its head office in Shanghai and liaison offices in cities such as Beijing, Guangzhou, Wuhan, Nanjing, Jinan, Hangzhou, Chongqing, and Chengdu, dedicated to the provision of high quality products and services to Chinese healthcare providers and patients.
About DePuy Synthes
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopedics portfolios in the world. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.depuysynthes.com.
About Johnson & Johnson Medical Devices Companies
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.
1 DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates
*The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopaedics, vision and interventional solutions businesses within the Johnson & Johnson's Medical Devices segment.